Your browser doesn't support javascript.
loading
Survey of Lifestyle, Past Medical History and Complementary and Alternative Medicine Use Among Adult Patients Participating in the National Cancer Institute's Exceptional Responders Initiative.
Olaku, Oluwadamilola; Conley, Barbara A; Ivy, S Percy; McShane, Lisa M; Staudt, Louis M; King, Sophie M; Sansevere, Megan; Kim, Benjamin; White, Jeffrey D.
Afiliação
  • Olaku O; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: olakuo@mail.nih.gov.
  • Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: tel124now@aol.com.
  • Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: Ivyp@ctep.nci.nih.gov.
  • McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: mcshanel@ctep.nci.nih.gov.
  • Staudt LM; Center for Cancer Genomics, National Cancer Institute, NIH, 31 Center Drive, Bethesda, MD 20892, USA. Electronic address: lstaudt@mail.nih.gov.
  • King SM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: Sophie.king@nih.gov.
  • Sansevere M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: megan.sansevere@nih.gov.
  • Kim B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: Benjamin.kim@nih.gov.
  • White JD; Division of Cancer Treatment and Diagnosis, National Cancer Institute, NIH, 9609 Medical Center Drive, Bethesda, MD 20892, USA. Electronic address: jeffreyw@mail.nih.gov.
Transl Oncol ; 25: 101484, 2022 Nov.
Article em En | MEDLINE | ID: mdl-35944413
INTRODUCTION: The Exceptional Responders Initiative (ERI) at the National Cancer Institute attempts to correlate unusually good outcomes in patients with cancer with genetic targets in tumors and the therapies the patients received. It is not known if other factors might contribute to exceptional responses or outcomes. We explored aspects of the medical history, lifestyle changes, complementary and alternative medicine (CAM) use and communication between health care practitioners and patients who experienced an exceptional response following cancer treatment. METHODS: All subjects whose case was submitted to the ERI were eligible to participate in the survey. A 121-question survey questionnaire was developed to assess aspects of the subject's past medical history, lifestyle (e.g., diet, exercise, spirituality) and use of CAM. RESULTS: Thirty subjects completed and returned the questionnaire from approximately 88 patients invited to participate (approximate response rate = 34%). Approximately 68% were female and 32% were male. Fifty percent of subjects changed their diet after their cancer diagnosis. Eighteen patients (60%) reported using a CAM therapy (not including oral vitamins/minerals or spiritual practices) during their Exceptional Response (ER). CONCLUSION: Multiple factors, including features of the tumor itself, the patient, or the environment, could affect tumor response or patient survival, either solely or in combination with the treatments received. Many patients use other medications, change their diet or physical activity or use CAM interventions after their cancer diagnosis. Investigators attempting to understand the exceptional response phenomenon should acquire rich data sets of their subjects that include information about these factors.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Oncol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Transl Oncol Ano de publicação: 2022 Tipo de documento: Article